Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(}function setPanelState(o){dom.root.classList[o?"add":"remove"](,dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Medexus Pharmaceuticals Inc TSX Venture: MDP-X

Today's Change
Real-Time Last Update TSX Venture Last Sale

Today's Trading

Day Low 6.900
Day High 7.140
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company. It is focused on auto-immune and pediatric diseases in the USA and Canada. The company's only reportable segment being the products sold and the marketing services offered to the pharmaceutical industry. Geographically, it derives a majority of revenue from the United States. Its product portfolio includes Rasuvo, Metoject, Rupall, Gliolan, and Treosulfan.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Strong Buy


A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.


What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Latest Press Releases

Sidoti Microcap Virtual Conference
- ACCESSWIRE - Tue May 18, 4:30PM CDT
Tue May 18, 4:30PM CDT
Medexus to Present at the Sidoti & Company Virtual Microcap Conference on May 19th
- GlobeNewswire - Wed May 12, 7:30AM CDT
GlobeNewswire - CMTX
Wed May 12, 7:30AM CDT
Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it will be presenting at the Sidoti & Company Virtual Microcap Conference being held on May 19- May 20, 2021.
Medexus Announces Conference Participation for April 2021
- GlobeNewswire - Mon Apr 12, 7:30AM CDT
GlobeNewswire - CMTX
Mon Apr 12, 7:30AM CDT
Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731), today announced that Ken d'Entremont, CEO, and Roland Boivin, CFO, will be participating in the Bloom Burton & Co. Healthcare Investor Conference as well as the Stifel 2021 Canada Cross Sector Insight Conference in the month of April.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 6.890 +0.87% increase
on 05/12/21
Period Open:7.300
Price movement based on the high, low and last over the given period.
7.750 -10.32% decrease
on 04/28/21
-0.350 (-4.79%) decrease
since 04/16/21
3-Month 6.550 +6.11% increase
on 03/05/21
Period Open:8.770
Price movement based on the high, low and last over the given period.
8.800 -21.02% decrease
on 02/19/21
-1.820 (-20.75%) decrease
since 02/18/21
52-Week 2.390 +190.79% increase
on 05/28/20
Period Open:2.750
Price movement based on the high, low and last over the given period.
9.750 -28.72% decrease
on 02/11/21
+4.200 (+152.73%) increase
since 05/15/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies